What we do
Tessa Therapeutics is a leading biotechnology company specializing in the research, clinical development, and commercialization of cancer immunotherapy treatments. We are a global leader in employing Virus-Specific T cells (VST) to treat cancer.
Why we do
We are proud to be spearheading innovation in the field of cancer immunotherapy for solid tumors and are committed to working towards our vision of a world without untreatable cancers.
